share_log

Chison Medical Technologies Co., Ltd. (SHSE:688358) Surges 15%; Private Companies Who Own 50% Shares Profited Along With Insiders

Chison Medical Technologies Co., Ltd. (SHSE:688358) Surges 15%; Private Companies Who Own 50% Shares Profited Along With Insiders

奇森医疗科技股份有限公司(上海证券交易所代码:688358)飙升15%;拥有50%股份的私营公司与内部人士一起获利
Simply Wall St ·  04/24 02:33

Key Insights

关键见解

  • Chison Medical Technologies' significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 2 shareholders own 64% of the company
  • 24% of Chison Medical Technologies is held by insiders
  • Chison Medical Technologies拥有大量的私营公司所有权,这表明关键决策受广大公众股东的影响
  • 前两名股东拥有公司 64% 的股份
  • 奇森医疗科技 24% 的股份由内部人士持有

To get a sense of who is truly in control of Chison Medical Technologies Co., Ltd. (SHSE:688358), it is important to understand the ownership structure of the business. We can see that private companies own the lion's share in the company with 50% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

要了解谁真正控制了奇生医疗科技股份有限公司(SHSE: 688358),了解业务的所有权结构非常重要。我们可以看到,私营公司拥有该公司的大部分股份,所有权为50%。也就是说,如果股票上涨,该集团将受益最大(如果出现低迷,则损失最大)。

While private companies were the group that benefitted the most from last week's CN¥433m market cap gain, insiders too had a 24% share in those profits.

尽管私营公司是从上周4.33亿元人民币的市值增长中受益最大的群体,但内部人士在这些利润中也占有24%的份额。

In the chart below, we zoom in on the different ownership groups of Chison Medical Technologies.

在下图中,我们放大了奇森医疗科技的不同所有权群体。

ownership-breakdown
SHSE:688358 Ownership Breakdown April 24th 2024
SHSE: 688358 所有权明细 2024 年 4 月 24 日

What Does The Institutional Ownership Tell Us About Chison Medical Technologies?

关于奇森医疗科技,机构所有权告诉我们什么?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见指数的回报进行比较。因此,他们通常会考虑收购相关基准指数中包含的大型公司。

We can see that Chison Medical Technologies does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Chison Medical Technologies' earnings history below. Of course, the future is what really matters.

我们可以看到,奇森医疗科技确实有机构投资者;他们持有该公司很大一部分股票。这可能表明该公司在投资界具有一定程度的信誉。但是,最好谨慎行事,不要依赖机构投资者所谓的验证。他们也是,有时候会弄错。如果多家机构同时改变对股票的看法,你可能会看到股价快速下跌。因此,值得在下面查看奇森医疗科技的收益记录。当然,未来才是真正重要的。

earnings-and-revenue-growth
SHSE:688358 Earnings and Revenue Growth April 24th 2024
SHSE: 688358 2024 年 4 月 24 日收益和收入增长

Chison Medical Technologies is not owned by hedge funds. Wuxi Chison Investment Co., Ltd. is currently the company's largest shareholder with 40% of shares outstanding. For context, the second largest shareholder holds about 24% of the shares outstanding, followed by an ownership of 4.2% by the third-largest shareholder. Ruoli Mo, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

奇森医疗科技不归对冲基金所有。无锡奇森投资有限公司目前是该公司的最大股东,已发行股份的40%。就背景而言,第二大股东持有约24%的已发行股份,其次是第三大股东持有4.2%的所有权。第二大股东莫若丽也恰好拥有首席执行官的头衔。

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

为了使我们的研究更有趣,我们发现前两名股东拥有公司的多数股权,这意味着他们足够强大,足以影响公司的决策。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

研究机构所有权是衡量和筛选股票预期表现的好方法。通过研究分析师的情绪也可以达到同样的目的。尽管有一些分析师的报道,但该公司的报道可能并不广泛。因此,在未来它可能会引起更多关注。

Insider Ownership Of Chison Medical Technologies

奇森医疗科技的内部所有权

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

尽管内部人士的确切定义可能是主观的,但几乎每个人都认为董事会成员是内部人士。公司管理层对董事会负责,后者应代表股东的利益。值得注意的是,有时高层管理人员自己也是董事会成员。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常认为内部所有权是一件好事。但是,在某些情况下,这使其他股东更难追究董事会对决策的责任。

Our information suggests that insiders maintain a significant holding in Chison Medical Technologies Co., Ltd.. Insiders own CN¥801m worth of shares in the CN¥3.4b company. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

我们的信息表明,内部人士持有奇生医疗科技有限公司的大量股份。内部人士拥有这家34亿元人民币公司价值8.01亿元人民币的股份。我们可以说这表明了与股东的一致性,但值得注意的是,该公司仍然很小;一些内部人士可能已经创立了该公司。你可以点击这里查看这些内部人士是否在买入或卖出。

General Public Ownership

一般公有制

With a 19% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Chison Medical Technologies. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Chison Medical Technologies拥有19%的所有权,主要是个人投资者,对奇森医疗科技有一定程度的影响力。这种所有权规模虽然可观,但如果决策与其他大股东不同步,可能不足以改变公司政策。

Private Company Ownership

私人公司所有权

It seems that Private Companies own 50%, of the Chison Medical Technologies stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

看来私营公司拥有奇森医疗科技50%的股份。可能值得对此进行更深入的研究。如果关联方,例如内部人士,对其中一家私营公司有兴趣,则应在年度报告中予以披露。私营公司也可能在公司中拥有战略利益。

Next Steps:

后续步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Chison Medical Technologies is showing 1 warning sign in our investment analysis , you should know about...

我觉得看看究竟谁拥有一家公司非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。请注意,奇森医疗科技在我们的投资分析中显示了1个警告信号,你应该知道...

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一样,你可能需要考虑这家公司是会成长还是会萎缩。幸运的是,您可以查看这份免费报告,其中显示了分析师对其未来的预测。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发